Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CLINICAL CORNER: New-Gen Bariatric Devices Show Promise With Positive Data

This article was originally published in Clinica

Executive Summary

Bariatric medicine for managing obesity and type 2 diabetes has advanced beyond surgical gastric bypass and gastric banding. The annual Digestive Disease Week (DDW) meeting in May highlighted a move towards novel minimally invasive technologies that do not require incisions, and others that do not even require endoscopic placement of the device. Highlights of the meeting include the clinical trial results from three promising technologies: GI Windows' Incisionless Anastomosis System, Allurion Technologies' Elipse Gastric Balloon, and Obalon Therapeutics' Obalon Gastric Balloon System

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register